Finally, apply your rich moisturizer to seal in your actives and protect your skin.

Coronary artery bypass graft (CABG) surgery remains the gold standard treatment for patients with severe atherosclerosis, but ...

They are beautiful, they are everywhere, and they are absurdly unknown: you are entirely forgiven if you've never heard of ...

A Novo Nordisk designed trial reports that their 25 mg oral semaglutide taken once daily produced greater mean weight ...

First-of-its-kind therapy developed by Johns Hopkins researchers cleared for treatment of Barth syndrome, a condition that ...

Patients taking the immunotherapy drug Keytruda (pembrolizumab) may now have the option to take it as a quick shot instead of ...

The ACHIEVE-3 trial was a 52-week, randomized, open-label study that included 1698 T2D patients inadequately controlled on metformin.

The FDA has approved updated labeling for Vyjuvek (beremagene geperpavec-svdt), a topical gene therapy for dystrophic epidermolysis bullosa.

The bispecific antibody linvoseltamab introduces a patient-centric advancement, with its response-adapted dosing regimen, a flexible approach that aims to reduce the treatment burden for patients ...

Through its “BMS Patient Connect” platform, the company is lowering out-of-pocket costs and providing nationwide shipping, ...

Learn how leading organizations are sparking innovation with AI. Provide employees and partners with a self-service HR assistant to help them access relevant knowledge articles, create and resolve ...